NCT07508800

Brief Summary

This study is focused on understanding the impact of time spent in nature (relative to an urban control) on stress, neural, and cardiac functioning in people experiencing high levels of stress, depression, and anxiety.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jan 2026Jun 2026

Study Start

First participant enrolled

January 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

March 17, 2026

Last Update Submit

March 30, 2026

Conditions

Keywords

nature; eeg; reward processing ; attention functioningstress

Outcome Measures

Primary Outcomes (2)

  • Brain functioning

    EEG (neural) measures of attention and reward processing ; resting EEG (including frequency-based analyses of canonical frequency bands, e.g., gamma, beta, alpha, delta, theta) and event-related potential measures (reflecting attention, e.g, P300 and reward/affective processing, e.g., reward positivity, late positive potential).

    ~1 hour after walking condition

  • Heart Rate Variability

    This measure reflect the variation in heart beat rate, over time. Specifically we will measure heart rate during the EEG recordings and calculate the RMSSD (Root Mean Square of Successive Differences) of heartbeat R-R intervals.

    ~ 1 hour after walking manipulaation

Study Arms (1)

Within-group study

individuals endorsing current high stress levels

Other: Nature vs. Urban walks

Interventions

We will evaluate the impact of spending time in nature vs. an urban control on EEG-based measures of reward and attention and resting heart rate variability

Within-group study

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals endorsing high stress levels will be recruited from the community and UCSF clinician outreach through flyer, media advertisements. Current or past depressive and anxiety disorders, if present, will be included due to their high prevalence and overlap with perceived stress.

You may qualify if:

  • Meets cut-off for high level of perceived stress on PSS-10 during screening (\>27 total score); Current or past depressive and anxiety disorders, if present on SCID-5 assessment, will be ncluded due to their high prevalence and overlap with perceived stress
  • Normal, or corrected to normal, vision (due to the visual nature of the EEG tasks)
  • If on psychotropic medication, stable regime for \> 1 month

You may not qualify if:

  • Major medical conditions with CNS sequelae (e.g., seizure disorders, multiple sclerosis, significant, uncontrolled cardiovascular pathology) Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive sequelae)
  • IQ estimate \<75 on the Test of Premorbid Functioning
  • Current or past history of severe mental illness (e.g., bipolar schizophrenia spectrum disorder, or current or past history of substance use disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of San Francisco California OR San Francisco VA Medical Center

San Francisco, California, 94122, United States

RECRUITING

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 17, 2026

First Posted

April 2, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations